Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older
Boonen, Steven × Black, Dennis M Colón-Emeric, Cathleen S Eastell, Richard Magaziner, Jay S Eriksen, Erik Fink Mesenbrink, Peter Haentjens, Patrick Lyles, Kenneth W #
Williams & Wilkins
Journal of the American Geriatrics Society vol:58 issue:2 pages:292-9
To determine the efficacy of once-yearly intravenous zoledronic acid (ZOL) 5 mg in reducing risk of clinical vertebral, nonvertebral, and any clinical fractures in elderly osteoporotic postmenopausal women.